ERICA FERRELL: Open Payments
NPI 1770793838 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 84 payments from 13 companies in 2025. Trend: 2023 $1,280 · 2024 $1,205 · 2025 $1,276
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $324 |
| ABBVIE INC. | 14 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $172 |
| Alkermes, Inc. | 11 | $167 |
| Neurocrine BioSciences, Inc. | 10 | $155 |
| Axsome Therapeutics, Inc. | 4 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: REXULTI, VRAYLAR, CAPLYTA, ARISTADA, INGREZZA, ABILIFY MAINTENA, Auvelity, Jornay PM.
Industry payments across NE — which companies pay providers there.
